Personal tools
You are here: Home Recent News FDA Advisory Panel Votes for Approval of New Diabetes Drug
Looking for information on Health Transformation in Washington State? Get info on upcoming webinars and the latest news at  
 HealthierWA

 
Log in


Forgot your password?
Become a Contributor
 

FDA Advisory Panel Votes for Approval of New Diabetes Drug

10 of 15 members of a Food and Drug Administration panel voted to recommend approval of diabetes drug canagliflozin, despite cardiovascular concerns.

"A US Food and Drug Administration advisory panel voted 10 to 5 in favor of approving the novel glucose-lowering agent canagliflozin (Invokana, Janssen Research & Development) for the treatment of adults with type 2 diabetes. But the FDA's Endocrinologic and Metabolic Drugs Advisory Committee also voted 8 to 7 that they had concerns about the cardiovascular safety of the agent."

Read more.

Document Actions